Active Stocks
Tue Mar 19 2024 13:41:05
  1. Tata Consultancy Services share price
  2. 4,004.65 -3.38%
  1. Tata Steel share price
  2. 150.30 0.47%
  1. Bharti Airtel share price
  2. 1,231.60 0.53%
  1. Power Grid Corporation Of India share price
  2. 260.35 -1.75%
  1. ITC share price
  2. 410.15 -1.74%
Business News/ Companies / News/  Delhi HC asks Malvinder, Shivinder to disclose value of unencumbered shareholdings
BackBack

Delhi HC asks Malvinder, Shivinder to disclose value of unencumbered shareholdings

Delhi HC allows Daiichi Sankyo to access previous asset declarations by the Singh brothers

The case will be heard next on 14 March. Photo: HTPremium
The case will be heard next on 14 March. Photo: HT

New Delhi: The Delhi high court on Monday directed Malvinder Singh and Shivinder Singh, former owners of Ranbaxy Laboratories Ltd, to file an affidavit disclosing the value of unencumbered shareholding in various entities.

The affidavit is to be submitted by 8 February.

Justice S. Muralidhar also allowed Daiichi Sankyo Co. Ltd of Japan to access previous asset declarations by the Singh brothers.

ALSO READ: Daiichi moves Delhi HC for restraining dilution of assets by Singh brothers

This came in response to an application by Daiichi Sankyo seeking to restrain the Singh brothers from selling assets, specifically Fortis Healthcare Ltd. The company said the Singhs were looking to rope in an investor in Fortis Healthcare and such a sale would dilute assets and hamper recovery of damages from the Singh brothers.

The case relates to enforcement of an arbitral award in proceedings initiated by Daiichi against the Singhs in relation to its 2008 purchase of a majority stake in Ranbaxy, then owned by the brothers.

The original arbitral award came after the Japanese company alleged that the Singh brothers had concealed crucial information while selling Ranbaxy to it for $4.6 billion in 2008. In response, a Singapore tribunal had ordered the brothers to pay Rs2,562 crore. The Singh brothers are contesting that.

ALSO READ: Japan’s raw deal shows India needs to cure Delhi belly

Sun Pharmaceutical Industries Ltd purchased Ranbaxy from Daiichi in a $3.2 billion acquisition it completed in 2015.

The case will be heard next on 14 March.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 23 Jan 2017, 08:13 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie